Abstract:Background: Cardiac ischemic injury induces a pathological remodeling response, which can ultimately lead to heart failure. Detailed mechanistic insights into molecular signaling pathways relevant for different aspects of cardiac remodeling will support the identification of novel therapeutic targets. Methods: Although genome-wide transcriptome analysis on diseased tissues has greatly advanced our understanding of the regulatory networks that drive pathological changes in the heart, this approach has been disadvantaged by the fact that the signals are derived from tissue homogenates. Here we used tomo-seq to obtain a genome-wide gene expression signature with high spatial resolution spanning from the infarcted area to the remote to identify new regulators of cardiac remodeling. Cardiac tissue samples from patients suffering from ischemic heart disease were used to validate our findings. Results: Tracing transcriptional differences with a high spatial resolution across the infarcted heart enabled us to identify gene clusters that share a comparable expression profile. The spatial distribution patterns indicated a separation of expressional changes for genes involved in specific aspects of cardiac remodeling, such as fibrosis, cardiomyocyte hypertrophy, and calcium handling (Col1a2, Nppa, and Serca2). Subsequent correlation analysis allowed for the identification of novel factors that share a comparable transcriptional regulation pattern across the infarcted tissue. The strong correlation between the expression levels of these known marker genes and the expression of the coregulated genes could be confirmed in human ischemic cardiac tissue samples. Follow-up analysis identified SOX9 as common transcriptional regulator of a large portion of the fibrosis-related genes that become activated under conditions of ischemic injury. Lineage-tracing experiments indicated that the majority of COL1-positive fibroblasts stem from a pool of SOX9-expressing cells, and in vivo loss of Sox9 blunted the cardiac fibrotic response on ischemic injury. The colocalization between SOX9 and COL1 could also be confirmed in patients suffering from ischemic heart disease. Conclusions: Based on the exact local expression cues, tomo-seq can serve to reveal novel genes and key transcription factors involved in specific aspects of cardiac remodeling. Using tomo-seq, we were able to unveil the unknown relevance of SOX9 as a key regulator of cardiac fibrosis, pointing to SOX9 as a potential therapeutic target for cardiac fibrosis.

Switching off SOX9 for epithelial recovery after AKI

SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys

A SOX9 switch from regeneration to fibrosis

Zinc finger protein 24-dependent transcription factor SOX9 up-regulation protects tubular epithelial cells during acute kidney injury

SOX9 is required for kidney fibrosis and activates NAV3 to drive renal myofibroblast function

Sox9-coordinated cellular neighborhoods generate fibrosis

Transient upregulation of EGR1 signaling enhances kidney repair by activating SOX9 + renal tubular cells

Transcription Factor Sox9 Exacerbates Kidney Injury through Inhibition of MicroRNA-96-5p and Activation of the Trib3/IL-6 Axis

TGF-β-mediated Upregulation of Sox9 in Fibroblast Promotes Renal Fibrosis

SOX9 reprograms endothelial cells by altering the chromatin landscape

Combined lineage tracing and scRNA‐seq reveal the activation of Sox9+ cells in renal regeneration with PGE2 treatment

Epigenetic reprogramming driving successful and failed repair in acute kidney injury

Airway epithelial cell identity and plasticity are constrained by Sox2 during lung homeostasis, tissue regeneration, and in human disease

Dissecting SOX9 dynamics reveals its differential regulation in osteoarthritis

Endothelial cells drive organ fibrosis in mice by inducing expression of the transcription factor SOX9

Dysregulated overexpression of Sox9 induces fibroblast activation in pulmonary fibrosis

Epigenetic regulation in the acute kidney injury to chronic kidney disease transition

Tomo-Seq Identifies SOX9 as a Key Regulator of Cardiac Fibrosis During Ischemic Injury

SOX9: a stem cell transcriptional regulator of secreted niche signaling factors

Flavin containing monooxygenase 2 regulates renal tubular cell fibrosis and paracrine secretion via SMURF2 in AKI‑CKD transformation

Role of CDKL1-SOX11 signaling axis in Acute Kidney Injury